Mayberry Investments Limited yesterday announced the retention of its services by Medical Disposables and Supplies Limited (MDS).

In a deal signed earlier this week, Mayberry will now act as the company’s investment banker, the firm said in a press release.

MDS is a leading distributor in the essential services market with its product portfolio centering around three key business areas: pharmaceuticals, medical supplies and general consumer items. The company services all pharmacies, hospitals, medical practitioners, medical labs, schools, hotels, nursing homes, and health and wellness institutions comprising hundreds of clients across Jamaica.

“We have been working with quite a few family owned businesses whose main aim is to provide superior customer service while enhancing value for potential investors. MDS is by no means an exception,” said Mayberry’s Senior Vice President of Corporate Finance, Research and Special Projects, Tania Waldron-Gooden.

MDS represents corporations such as GlaxoSmithKline (GSK) and Dr Reddy’s Laboratories (DRL) – a leading global branded generic company headquartered in India. The company also acts as a supplier channel for a number of US based companies including Victus Inc, Alconox Inc and Surgi-Med Corporation.

Locally, the company is engaged in sub-distributorship arrangements with Cari-Med, Kirk Distributors, Supreme Chemicals , Consumer Brands, Smith Russell and Health Brands.

Kurt Boothe, General Manager of MDS noted that “while the company started out as a provider of hospital sundries, it has expanded within a relatively short period of time, extending the product catalogue through the inclusion of ethical pharmaceuticals and consumer goods. This path of managed growth and strategic development promises to deliver continued returns along with the synergies achieved from the Mayberry alliance”.

MDS opened its doors in 1999 and operates out of Kingston, Jamaica.